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Abstract
Inflammatory leiomyosarcoma (ILMS) is a soft tissue tumor that morphologically resembles conventional leiomyo-
sarcoma (LMS) admixed with a prominent inflammatory infiltrate. Genetic data on ILMS are still limited but have
suggested that this entity is characterized by hyperhaploidy (24–34 chromosomes). This low chromosome number
is otherwise uncommon in neoplasia and has been found only in 0.2% to 0.3% of cytogenetically investigated tumors.
Here, three ILMS were investigated using cytogenetic, single-nucleotide polymorphism (SNP) array, and global gene
expression analyses. All cases displayed a hyperhaploid origin. Combined with previously reported cases, hyper-
haploidy has been found in six of seven cytogenetically investigated ILMS. The copy number distribution of individual
chromosomes is clearly nonrandom; the hyperhaploid clones of all six cases displayed disomy for chromosomes 5
and 20, and two copies of chromosomes 18, 21, and 22 were also common. All chromosomes identified as disomic
showed a biparental origin by SNP array analysis; whether this is of pathogenetic importance is not known. Compared
with conventional LMS, ILMS had a distinct gene expression signature. Furthermore, the number of chromosome
copies correlated well with gene expression levels; disomic chromosomes showed higher gene expression levels
than monosomic chromosomes, a finding that has not previously been reported for hyperhaploid tumors. Taken
together, our findings suggest that disomy for some chromosomes, notably 5 and 20, as well as distorted gene
expression achieved through massive loss of other chromosomes are essential features of ILMS.
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Introduction
In 1995, Merchant et al. described a fascicular spindle cell tumor of the
deep soft tissues that showed morphologic features in common with
leiomyosarcomas (LMS) as well as a prominent inflammatory compo-
nent [1]. The new entity was termed inflammatory LMS (ILMS). Some
of the described tumors had originally been included in the hetero-
geneous group of so-called inflammatorymalignant fibrous histiocytoma.
However, ILMS should be distinguished from both inflammatory and
pleomorphic malignant fibrous histiocytomas, which are poorly defined
undifferentiated sarcomas with poor prognosis [2,3].
Abbreviations: ALL, acute lymphoblastic leukemias; FDR, false discovery rate; GSEA, gene
set enrichment analysis; HCL, hierarchical clustering analysis; ILMS, inflammatory
leiomyosarcoma; LMS, leiomyosarcoma; LOH, loss of heterozygosity; PCA, principal
component analysis; SNP, single-nucleotide polymorphism; UPID, uniparental isodisomy
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Cytogenetic analyses have suggested that ILMS has distinct genomic
features characterized by a hyperhaploid chromosome complement,
i.e., 24 to 34 chromosomes [4]. Karyotypes from four ILMS have been
reported, three of which showed fewer than 35 chromosomes [4,5].
In general, this genetic pattern is uncommon in neoplasia; only 0.2%
to 0.3% of cytogenetically investigated tumors have shown a chromo-
some number in the near-haploid range [6]. However, in certain tumor
types, distinct subgroups with hyperhaploid chromosome numbers can
be discerned. About 0.5% to 1% of acute lymphoblastic leukemias
(ALL) and about 5% of chondrosarcomas have displayed hyperhaploid
chromosome numbers. Moreover, in an unselected series of chondro-
sarcomas, global DNA copy number analyses using single-nucleotide
polymorphism (SNP) arrays have indicated that an additional subset
of tumors have gone through a hyperhaploid stage [7]. To identify
genomic aberrations and determine their impact on gene transcription
in ILMS, we have here combined information from cytogenetic, SNP
array, and global gene expression analyses.
Materials and Methods
Patients and Tumor Material
Three tumors with histologic features compatible with ILMS were
included (Figure 1 and Table 1; cases 1–3) [1]. All of them affected
adult men (age range, 24–52 years). The tumors ranged in size from
6 to 9 cm and were located in the thigh (two patients) or arm. Fifteen
conventional LMS (5 spindle cell and 10 not otherwise specified)
were included for comparison in the global gene expression analysis
(TableW1). All patients with LMSwere adults (age range, 46–86 years;
eight men, seven women). All samples were obtained after informed
consent, and the study has been approved by the Lund University Ethics
Review Board.
DNA and RNA Extractions
DNA and RNA were extracted from fresh frozen tumor biopsies
using the DNeasy tissue kit including the optional RNaseH treatment
and the RNeasy lipid tissue kit, according to the manufacturer’s in-
structions (Qiagen, Hilden, Germany). Quality and concentration of
the extracted material were measured with a 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA) and NanoDrop ND-1000 (Thermo
Fisher Scientific, Waltham, MA).
Cytogenetic Analyses
Cytogenetic analyses were performed according to standard proce-
dures, and karyotypes were written following the recommendations of
the International System for Human Cytogenetic Nomenclature (ISCN)
(Tables 1 and W1) [8]. None of the 15 control LMS displayed a near-
haploid karyotype; all cases showed abnormal karyotypes with near-
diploid (11 cases), near-triploid (3 cases), or near-tetraploid (1 case)
chromosome numbers (Table W1). The complexity of the cytogenetic
changes ranged from supernumerary ring and marker chromosomes as
the sole anomalies to highly aberrant karyotypes with multiple gains,
losses, and structural rearrangements.
Genomic Copy Number and Loss of Heterozygosity Analyses
SNP array analysis was used for combined DNA copy number and
loss of heterozygosity (LOH) investigation. TumorDNAwas hybridized
Figure 1. Morphologic and immunophenotypic appearance of an ILMS (case 2). (A) Medium-power (H&E, ×20) view showing fascicles
of spindle cells admixed with inflammatory cells. (B) Strong and diffuse positivity for desmin (×10).
Table 1. Clinical and Cytogenetic Features of ILMS.
Case Age/Sex Location Grade (1–3) Size (cm) Follow-up (months)* Karyotype† Reference‡
1 52/M Lower arm 2 8 36 NED 51-53,X,−Y,+X,+5,+5,+18,+18,+20,+20,+21,+21,+22,+22 Present study
2 41/M Thigh ? 9 LTF 26,X,+5,+20,+22/26,idem,r(?15)/52,idemx2/51-52,idemx2,r(?15)x2/102-104,idemx4,inc Present study
3 24/M Thigh 2 6 120 NED 27,X,+Y,+5,+der(20)t(X;20)(p2?1;q13.3),+22/27-28,idem,+r/54,idemx2 Present study
4 53/M Thigh III§ 3 18 NED 28,X,+5,+18,+20,+21,+22/56,idemx2 7758; case 4
5 20/M Thigh NA 4 NA 28,X,+5,+18,+20,+21,+22/29,idem,+r 7758; case 5
6 64/F Thigh NA 12 22 M 25-28,add(X)(q26),add(3)(q29),+5,+8,+20,+21,+1-2r/47-53,add(X)x2,+4,+5,+5,+20,+20,+21,+21 11143; case 1
41 NED
7 32/M Lung NA 3.5 NA 46,XY,del(8)(p21p23)/46,XY,del(9)(q11) 11143; case 3
*NED, no evidence of disease; LTF, lost to follow-up; NA, not available; M, metastasis.
†The karyotypes are based on information from G-banding and, in case 3, fluorescence in situ hybridization analyses.
‡Reference numbers correspond to publications in theMitelmanDatabase of Chromosome Aberrations and Gene Fusions inCancer (2012;Mitelman F, Johansson B andMertens F (Eds.), http://cgap.nci.nih.gov/
Chromosomes/Mitelman).
§III, grade 3 in a four-grade malignancy scale; NA, not available.
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onto Illumina Human CNV370 version 1.0 and Illumina Human
CNV370-Quad version 3.0 BeadChips, containing ∼370,000 markers,
following standard protocols supplied by the manufacturer (Illumina,
San Diego, CA). Data analysis was performed using the GenomeStudio
software (Illumina), detecting imbalances by visual inspection. Con-
stitutional copy number variations were excluded through compari-
son with the Database of Genomic Variants (http://projects.tcag.ca/
variation/) [9].
Global Gene Expression Profiling
Global gene expression analyses were performed using Affymetrix
Human Gene 1.0 ST Arrays according to the manufacturer’s instruc-
tions (Affymetrix, Santa Clara, CA). Included in the analyses were
3 ILMS and 15 control LMS. The control tumors were selected on the
basis of their histologic resemblance to ILMS and the fact that well-
differentiated LMS previously have shown a distinct gene expression
signature, separate from the group of poorly differentiated pleomorphic
sarcomas formerly known as “malignant fibrous histiocytomas” [10].
In addition, the control tumors did not show any cytogenetic sign of a
hyperhaploid origin (Table W1). Gene expression data were normalized,
background-corrected, and summarized by using the Robust Multichip
Analysis (RMA) algorithm implemented in the Expression Console
version 1.1 software (Affymetrix). To reduce batch effects, we adjusted
normalized data using the ComBat algorithm (Figure W1) [11].
Correlation-based principal component analysis (PCA) and hierarchical
clustering analysis were performed using the Qlucore Omics Explorer
version 2.2 (Qlucore AB, Lund, Sweden). Differences between tumor
groups in log2 transformed expression data were calculated using a
t test, and corrections for multiple testing were based on the Benjamini-
Hochberg method (Qlucore AB). Genes with P < .05 and a false
discovery rate (FDR) < 0.2 were considered significantly altered.
Microarray data have been deposited in the Gene Expression Omnibus
database (www.ncbi.nlm.nih.gov/geo, Accession No. GSE38104).
Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA) can be used to calculate
whether a defined set of genes shows statistically significant differences
between two groups [12,13]. Here, the method was applied to the
RMA-normalized and ComBat-adjusted gene expression data described
above using gene sets corresponding to each chromosome, except the
sex chromosomes. The chromosomal location of each gene was extracted
from the annotation file HuGene-1_0-st-v1_na27_hg18 (Affymetrix).
GSEA was performed using default settings for adjustable parameters,
except for the size of the gene sets, which was adjusted to include gene
sets for all autosomes, and the permutation type; P values were estimated
by permuting the genes.
Correlation between Gene Expression Levels and Number of
Chromosome Copies
The mean expression value for each gene was calculated in the groups
of ILMS and LMS, respectively. The normalized intensity value in ILMS
was subsequently divided with the corresponding value in LMS. Genes
with a ratio >1 thus showed a higher expression in ILMS than in LMS.
Each chromosome contained between 268 and 2242 genes, and for
each chromosome, the mean and median gene expression ratios were
extracted. The mean gene expression values were subsequently correlated
with the relative number of chromosome copies.
Results
Both Parental Copies of Chromosomes 5, 20, and 22 Are Retained,
whereas the Remaining Autosomes Most Often Display LOH
Case 1 showed a hyperdiploid karyotype with two copies of all
autosomes except 5, 18, 20, 21, and 22, which were all present in four
copies (Table 1). These five chromosomes displayed relative gain and
retained heterozygosity by SNP array analysis and all other autosomes
showed LOH (Table 2). The karyotype and the SNP array results
strongly suggest that the hyperdiploid clone detected by G-banding
analysis originated from a hyperhaploid clone. Case 2 showed rela-
tive gains of chromosomes 5, 20, and 22 in clones at different ploidy
levels ranging from hyperhaploidy to hypertetraploidy (Table 1). No
other gains or losses were detected by SNP array analysis (Table 2). By
G-banding analysis, some clones displayed a ring chromosome possibly
consisting of chromosome 15 material. Case 3 displayed a karyotype
that agreed well with the relative gain and retained heterozygosity for
chromosomes 5, 20, and 22 revealed by SNP array analysis (Tables 1
and 2). The SNP array data also showed relative gain and retained hetero-
zygosity for chromosome 21 in a subclone of the investigated material.
In summary, all three cases presented hyperhaploid clones and/or
duplicates of such clones. Numerical imbalances involved losses and/
or gains of whole chromosomes; no small imbalance was detected.
Structural rearrangements were confined to a translocation in case 3
and ring chromosome formation in subclones of cases 2 and 3. Both
parental copies of chromosomes 5, 20, and 22 were present in all three
cases. Retained heterozygosity was also detected for chromosome 18
in case 1 and chromosome 21 in cases 1 and 3. All other autosomes
displayed LOH as a result of chromosome loss and, in some cases,
subsequent duplication of the remaining homologue giving rise to
uniparental isodisomy.
ILMS Has a Distinct Gene Expression Profile
Unsupervised PCA demonstrated clearly distinct gene expression
profiles for the ILMS compared with the LMS controls (Figure 2). On
Table 2. SNP Array Findings in Three ILMS*.
Chromosome Case 1 Case 2 Case 3
1 LOH LOH LOH
2 LOH LOH LOH
3 LOH LOH LOH
4 LOH LOH LOH
5 RH RH RH
6 LOH LOH LOH
7 LOH LOH LOH
8 LOH LOH LOH
9 LOH LOH LOH
10 LOH LOH LOH
11 LOH LOH LOH
12 LOH LOH LOH
13 LOH LOH LOH
14 LOH LOH LOH
15 LOH LOH LOH
16 LOH LOH LOH
17 LOH LOH LOH
18 RH LOH LOH
19 LOH LOH LOH
20 RH RH RH
21 RH LOH RH†
22 RH RH RH
*RH, relative gain of chromosomes with retained heterozygosity.
†Relative gain and retained heterozygosity for chromosome 21 were detected in a subclone.
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the basis of the expression of the 989 most variable genes (σ/σmax =
0.4), 138 genes showed significantly different expression values be-
tween the two groups; 56 genes showed higher and 82 genes showed
lower expression levels in ILMS compared with LMS (Figure 2 and
Tables W2 and W3).
Genes on the Disomic Chromosomes 5, 20, and 22 Show
High Expression Levels in ILMS
Using gene sets representing each autosome, GSEA showed a good
correlation between transcriptional levels and gene copy numbers.
Transcripts from chromosomes 5, 20, 21, and 22 were found to be
Figure 2. ILMS shows distinct gene expression features. (A) Unsupervised PCA based on the expression of the 989 most variable genes
(σ/σmax = 0.4) shows that the three ILMS (red) form a group that has an expression profile separate from the 15 LMS (green). The first
three principal components, representing 19%, 14%, and 12% of the variance, are displayed. Of the 989 most variable genes, 138 genes
showed a significantly different expression between the two tumor groups (P < .05, FDR < 0.2; Tables W2 and W3). (B) The differentially
expressed genes are displayed in a supervised hierarchical clustering analysis. Genes with high and low expression values are labeled in
red and green, respectively.
Figure 3. Gene sets for chromosomes 5, 20, and 22 are enriched in ILMS. GSEA was performed using gene sets corresponding to each
autosome. Genes on chromosomes 5, 20, 21, and 22 show enrichment in ILMS, whereas genes on chromosomes 4, 6, 8, 12, 14, and
15 show the opposite pattern, i.e., enrichment in the control group of conventional LMS (P < .01 and FDR < 0.01). A ranked gene list,
represented by the red and blue heat maps, is created on the basis of the gene expression values in the two groups. The black lines cor-
respond to the location of the genes from the respective gene set in the sorted lists. The enrichment profiles show the running sum (green
line) for the particular gene set. This value is calculated by walking down the ranked gene list and increasing the score when encountering
a gene in the gene set and decreasing when encountering genes not in the gene set [12]. The enrichment profiles thus show if the mem-
bers of a gene set are randomly distributed throughout the ranked gene list or primarily found at the top or bottom. A gene set with the
latter distribution is expected to be related to the phenotype. The images were extracted from the GSEA software [12,13].
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enriched in ILMS, whereas transcripts from chromosomes 4, 6, 8, 12,
14, and 15 were enriched in LMS (P < .01 and FDR < 0.01; Figure 3).
The average gene expression levels per chromosome, calculated using
normalized intensity values, were compared between the tumor
groups, and the highest ratios (ILMS/LMS) were detected for chromo-
somes 5, 20, and 22 (Figure 4A). The relative number of chromosome
copies, compared to the haploid state, was 2 for chromosomes 5, 20,
and 22, 1.67 for chromosome 21, 1.33 for chromosome 18, and 1 for
the remaining autosomes (Table 2). Correlation analysis showed a
good correlation between average gene expression level and number
of chromosome copies (R = 0.84; Figure 4B).
Discussion
Five of seven cytogenetically investigated ILMS have shown a hyper-
haploid chromosome number (Table 1). In addition, a sixth case
(case 1 of the present study) showed a hyperdiploid karyotype contain-
ing exclusively disomic and tetrasomic chromosomes. The tetrasomic
chromosomes consisted of two maternal and two paternal homologues,
and all disomic chromosomes were uniparental isodisomies. This pat-
tern of aberrations strongly indicates a hyperhaploid origin where the
original clone has doubled the entire set of chromosomes, most likely
trough a single event. Thus, we can confirm the previously suggested
high frequency of hyperhaploidy in ILMS.
Hyperhaploidy is thought to be a relatively rare phenomenon in
neoplasia. However, the incidence estimates of this extreme chromo-
some number are primarily based on cytogenetic analyses of cultured
tumor cells [6]. Because this technique does not reveal the parental
origin of the chromosomes, it is possible that a subset of tumors
with higher chromosome numbers has passed through an undetected
hyperhaploid stage. In line with this, still limited SNP array data
on chondrosarcomas suggest that the majority of cases with more
than 46 chromosomes originate from a hyperhaploid or hypodiploid
precursor [7]. Thus, hyperhaploidy may be more common than
suggested by cytogenetic studies.
Although the number of investigated cases remains low, it can be
concluded that the copy number distribution of individual chromo-
somes is clearly nonrandom in ILMS; all six cases with a hyper-
haploid origin have shown disomy for chromosomes 5 and 20, and
two copies of chromosomes 18, 21, and 22 are also common (Table 1).
In a recent review of the karyotypic patterns in hyperhaploid neo-
plasms, it was found that bone and soft tissue tumors displayed non-
random patterns with respect to retained disomies; chromosomes 5 and
20 are most often disomic in soft tissue tumors and chromosomes 5, 7,
and 20 are rarely monosomic in chondrosarcoma [6]. In hyperhaploid
ALL, however, there is preferential retention of chromosomes 14, 18,
21, and X [14], and also other tumor types, that less frequently show
hyperhaploidy seem to have nonrandom distribution of monosomies
and disomies [6].
The pathogenetic impact of hyperhaploidy is not easily explained.
Many hyperhaploid tumors show subpopulations of hyperdiploid to
hypertetraploid clones, which sometimes constitute the majority of
investigated cells. It thus seems unlikely that it is the low chromosome
number as such that is crucial for tumor development. More likely,
the combination of lost and retained chromosomes is important. One
potential pathogenetic mechanism is that the widespread LOH found
in hyperhaploid tumors is vital for tumorigenesis by unmasking recessive
mutations. The explanation for the fact that both parental copies of
some chromosomes are consistently retained could then be that loss
of any of these chromosomes would be lethal for the tumor cells. How-
ever, it seems unlikely that the pathogenetic consequences of deleting
almost half of the genome would be to reveal a few potentially delete-
rious mutations. In this context, it could be of interest to note that none
of the present tumors showed microdeletions, which is in contrast to
hyperhaploid chondrosarcoma and ALL [7,15]. Therefore, perhaps a
more likely possibility would be that hyperhaploidy results in multiple
gene dosage imbalances that distort the global gene expression profile.
In support of this hypothesis, there was a clear correlation between gene
copy number and level of expression; genes on disomic chromosome
were enriched in ILMS and disomic chromosomes showed higher
average gene expression levels than monosomic chromosomes. Thus,
extensive allelic loss through whole chromosome deletions coupled
with retention of other chromosomes may favor the impact of dosage-
sensitive genes [16,17].
It is conspicuous that chromosomes 5, 20, and 22 were hetero-
disomic in all cases investigated and that nonrandom patterns of re-
tained heterodisomy have been reported also in chondrosarcoma and
ALL [7,15]. Obviously, disomy for certain tumor-specific chromo-
somes is of importance for hyperhaploid tumor development. However,
it is not known whether the preservation of both parental homologues,
as in contrast to isodisomy, is a consequence of the mechanism by
Figure 4. Heterodisomic chromosomes 5, 20, and 22 display high average gene expression levels. (A) The mean expression value was
calculated for each gene in ILMS and conventional LMS, respectively. The normalized intensity value in ILMS was divided by the
corresponding value in LMS. Genes with a ratio >1 thus showed a higher expression in ILMS. For each chromosome, containing between
268 and 2242 genes, the average gene expression level was estimated by calculating the mean (black) and median (gray) gene ratios. The
highest average gene expression ratios were detected for chromosomes 5, 20, and 22. (B) The relative number of chromosome copies
(2 for chromosomes 5, 20, and 22, 1.67 for chromosome 21, 1.33 for chromosome 18, and 1 for the remaining autosomes) correlated well
with the average gene expression level of the respective chromosomes (R = 0.84).
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which the hyperhaploid cells originate or if it is of pathogenetic signifi-
cance. In normal diploid cells, some genes are functionally hemizygous
because of parental imprinting, a silencing mechanism that results in
directed transcription of an allele from only one parent [18]. Although
the exact prevalence is not known, it has been estimated that around
1% of human genes is affected by parental imprinting, and by com-
putational analysis, these genes have been predicted to be present in
all autosomes [19]. Furthermore, monoallelic gene expression has also
been shown to occur because of random inactivation of maternal or
paternal alleles, i.e., some cells express the maternal allele and others
express the paternal allele; a pattern of expression that is maintained
in daughter cells [20]. It is thus possible that the nonrandom pattern
of chromosome aberrations found in hyperhaploid tumors is influenced
by monoallelic gene transcription.
In conclusion, we confirm that hyperhaploidy is a distinguishing
characteristic of ILMS and show that disomy for some chromosomes,
notably 5 and 20, as well as distorted gene expression achieved through
massive loss of other chromosomes are essential features of ILMS.
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Table W1. Cytogenetic Features of LMS.
Case Diagnosis* Publication† Karyotype‡
8 LMS, NOS Ref. 11719, case 13 47-49,XX,+1-2r,+mar
9 LMS, NOS Ref. 10805, case 35 43-47,X?,+1-4r,inc/83-90,idemx2
10 LMS, NOS 45-47,X,−Y/45-47,idem,+r/47-50,XY,+1-3r
11 LMS, NOS 41-43,XY,del(1)(q11),−2,−6,−9,−10,−12,−13,−17,−18,+r,+3mar/79-85,idemx2,inc
12 LMS, NOS 43-47,XY,−5,+2mar/92-93,idemx2
13 LMS, NOS 39-49,XY,−3,+2-6r/85-92,XXYY,+5-9r,inc
14 LMS, NOS 86-99,X?,add(1)(q21),?del(1)(p11),add(11)(q23), add(19)(q13),+2-6r,inc
15 LMS, NOS 44-48,XX,t(9;13)(q33;q21),+0-3r,+0-2mar/89-92,idemx2
16 LMS, NOS 46,XY,del(3)(q25),−7,add(14)(q32),+r
17 LMS, NOS 61-73,X?,add(1)(p11),ins(1;?)(p13;?),del(7)(q22), del(7)(q31),+3-4r,inc
18 LMS, spindle cell Ref. 8300, case 3 44,X,add(X)(p22),−10,−13,add(15)(q15),add(16)(q24),der(16)t(15;16)(q15;p13), add(17)(p11),−22,
+r/43,idem,−2/45,idem,+8
19 LMS, spindle cell Ref. 8300, case 2 67-75,X,add(X)(q28),del(X)(q23),der(1;?)inv(1)(p12p36)dic(1;?)(p12;?)x2,add (3)(p14),del(3)(p14),
del(3)(q12),add(4)(p16)x2,add(5)(q35),del(6)(q15)x2, der(7)del(7)(p13)ins(7;?)(q32;?),ins(7;?)(q32;?),
inv(7)(p15p22),del(8)(p21), add(10)(p15),del(11)(p12)x2,del(11)(q11),add(12)(q24),add(13)(p11),
der (14)add(14)(p11)add(14)(q32)x3,add(16)(p13)x2,add(17)(q25),der(18)add(18) (p11)add(18)(q23),
add(19)(p13)x2,add(22)(p11),+hsr(?),inc
20 LMS, spindle cell Ref. 5609, case 40; 8300, case 1 45-51,XY,der(1)del(1)(p36)add(1)(q32),add(3)(p25),add(7)(p11),del(7) (q11q22),add(12)(q24),
add(17)(q25),add(19)(q13),der(19)t(5;19) (q13;p11)/45-49,idem,−add(3),+del(3)(q11)/81-97,idemx2,
−add(3)x2,+del (3)x2/42-44,idem,add(1)(q32),del(4)(p14),add(5)(p15),−del(7),−add(19),−der (19)
21 LMS, spindle cell Ref. 8300, case 5 40-42,XY,der(1)del(1)(p32)add(1)(q44),add(3)(q11),der(3)del(3)(p13p23)t (3;12)(q29;q13),−4,−5,−5,
−9,−9,del(12)(q13),−13,−14,−14,der(15)t(15;15) (p11;q13),der(16)t(12;16)(q13;q24)ins(16;?)(q24;?),
−17,−17,−18,+der(?)t (?;11)(?;q14)hsr(11)(q14),+5mar/70-83,X?,del(1)(p12),der(1)add(1)(p11)add(1)
(q42-44)x2,add(3)(p21),add(12) (p13),del(12)(q13),der(15)t(15;15),inc
22 LMS, spindle cell Ref. 8300, case 6 75-78,XXX,+X,+1,der(1;6)(q10;p10)x2,−2,+3,−4,+5,+6,+7,+8,+9,−10,+11,+12,−13, add(15)(p13)x2,
+16,+18,+19,+20,der(20)t(4;20)(q11;q13)ins(20;?)(q13;?)x2, +21,+22/76-77,idem,add(17)(q25)
*NOS, not otherwise specified.
†Reference numbers are from the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2012).
‡Karyotypes are described according to ISCN (2009) [8].
Figure W1. The ComBat algorithm was applied to adjust for batch effects when combining the two batches of global gene expression
data. (A) Unsupervised PCA of RMA-normalized global gene expression data showed that the samples clustered according to batch
rather than in line with any biologic feature. One sample (marked by a triangle) was analyzed in both batches. This case clustered more
closely together with samples of the same batch than to its replica in the other batch. (B) After data adjustments using the ComBat
algorithm, the obvious batch effects were eliminated. The duplicates of the same sample now clustered close to each other. (C) An
apparent difference in global gene expression patterns between ILMS and other LMS could be discerned. The first three principal com-
ponents are shown in each plot, and the proportions of the variance represented by each component are displayed within parentheses.
